Share Price and Basic Stock Data
Last Updated: December 20, 2025, 4:42 pm
| PEG Ratio | -2.26 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Panama Petrochem Ltd operates in the chemicals sector, primarily focused on specialty chemicals. The company has exhibited robust revenue growth, with sales rising from ₹2,132 Cr in FY 2022 to ₹2,249 Cr in FY 2023, and further to ₹2,357 Cr in FY 2024. The trailing twelve months (TTM) sales have now reached ₹2,815 Cr, indicating a healthy upward trajectory. Quarterly sales figures reflect fluctuations, with a notable peak of ₹741 Cr in Mar 2024, though there was a dip to ₹512 Cr in Dec 2023. Despite these oscillations, the overall trend appears positive, as evidenced by the annual growth rate. The company’s ability to maintain sales momentum amidst market fluctuations suggests a resilient business model, likely driven by strong demand in the specialty chemicals sector.
Profitability and Efficiency Metrics
Profitability metrics for Panama Petrochem showcase a mixed but generally positive picture. The operating profit margin (OPM) has seen a gradual decline, from 14% in FY 2022 to 9% in FY 2025, which raises concerns about cost management in a competitive environment. Nonetheless, the net profit for FY 2023 was reported at ₹233 Cr, marginally declining to ₹187 Cr in FY 2025, yet it remains commendable given the challenges faced in the sector. The return on equity (ROE) stood at 14.9% for FY 2025, reflecting a decent return for shareholders, though it has decreased from higher levels in previous years. The interest coverage ratio (ICR) of 14.26x suggests a comfortable position in servicing debt, indicating that operational profitability remains sound despite rising expenses.
Balance Sheet Strength and Financial Ratios
Panama Petrochem’s balance sheet reflects a robust financial position. The company reported total assets of ₹1,524 Cr and minimal borrowings of ₹31 Cr, demonstrating a strong equity base with a debt-to-equity ratio of nearly zero. This low level of leverage indicates that the company is not heavily reliant on debt, which can be a significant advantage during economic downturns. Reserves have grown impressively, reaching ₹1,328 Cr, which not only strengthens the balance sheet but also provides a cushion for future investments. However, the current ratio of 5.18 suggests that while liquidity is strong, it may also indicate an inefficient use of assets. Investors might want to keep an eye on how effectively the company converts its assets into revenue-generating opportunities.
Shareholding Pattern and Investor Confidence
The shareholding structure of Panama Petrochem shows a healthy mix of promoter and institutional ownership, with promoters holding 62.51% of the shares, indicating strong insider confidence in the company’s prospects. Foreign institutional investors (FIIs) have increased their stake to 12.02%, suggesting growing interest from external investors, while domestic institutional investors (DIIs) remain minimal at 0.47%. The public shareholding stands at 24.99%, reflecting a stable retail investor base. The gradual decline in promoter holding from 70.37% in late 2022 to the current level may raise questions about dilution, but it could also be a strategic move to attract more institutional investment. Overall, the diverse ownership structure appears to bolster investor confidence, although the decreasing promoter share could warrant closer monitoring.
Outlook, Risks, and Final Insight
Looking ahead, Panama Petrochem faces both opportunities and challenges. The company’s strong fundamentals, underscored by solid revenue growth and a robust balance sheet, position it well for future expansion in the specialty chemicals market. However, the declining profitability margins and fluctuating sales figures raise concerns about operational efficiency and market competition. Additionally, while the low debt levels provide a buffer, rising input costs could impact margins further. Investors should remain vigilant regarding the company’s ability to navigate these challenges while capitalizing on growth opportunities. The evolving market landscape, combined with the company’s existing strengths, suggests that while the outlook is cautiously optimistic, potential risks should not be underestimated. For investors, this stock could represent a compelling opportunity, but careful consideration of the operational dynamics will be essential for informed decision-making.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 394 Cr. | 42.9 | 83.5/41.2 | 24.5 | 20.5 | 0.93 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 29.2 Cr. | 59.5 | 93.8/56.0 | 14.0 | 89.6 | 1.68 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.6 Cr. | 729 | 953/600 | 22.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,399 Cr. | 75.0 | 111/74.1 | 22.5 | 22.0 | 0.67 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 643 Cr. | 258 | 404/241 | 23.1 | 93.8 | 0.97 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,808.84 Cr | 727.68 | 74.84 | 183.02 | 0.45% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 552 | 614 | 573 | 510 | 530 | 574 | 512 | 741 | 671 | 699 | 728 | 695 | 693 |
| Expenses | 465 | 525 | 505 | 444 | 471 | 513 | 456 | 664 | 605 | 641 | 665 | 636 | 638 |
| Operating Profit | 86 | 89 | 68 | 66 | 58 | 61 | 56 | 77 | 66 | 58 | 63 | 59 | 55 |
| OPM % | 16% | 14% | 12% | 13% | 11% | 11% | 11% | 10% | 10% | 8% | 9% | 9% | 8% |
| Other Income | 1 | 1 | 1 | 3 | 5 | 4 | 2 | 5 | 2 | 3 | 4 | 4 | 4 |
| Interest | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 4 | 6 | 4 | 5 | 3 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 4 | 3 | 3 |
| Profit before tax | 83 | 85 | 64 | 63 | 57 | 58 | 52 | 74 | 61 | 53 | 59 | 55 | 53 |
| Tax % | 22% | 21% | 21% | 19% | 19% | 20% | 20% | 17% | 18% | 16% | 18% | 20% | 19% |
| Net Profit | 65 | 67 | 50 | 51 | 46 | 47 | 41 | 61 | 50 | 44 | 48 | 44 | 43 |
| EPS in Rs | 10.68 | 11.15 | 8.29 | 8.40 | 7.59 | 7.76 | 6.84 | 10.08 | 8.29 | 7.29 | 8.02 | 7.32 | 7.05 |
Last Updated: August 1, 2025, 3:55 pm
Below is a detailed analysis of the quarterly data for Panama Petrochem Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 693.00 Cr.. The value appears to be declining and may need further review. It has decreased from 695.00 Cr. (Mar 2025) to 693.00 Cr., marking a decrease of 2.00 Cr..
- For Expenses, as of Jun 2025, the value is 638.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 636.00 Cr. (Mar 2025) to 638.00 Cr., marking an increase of 2.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 55.00 Cr.. The value appears to be declining and may need further review. It has decreased from 59.00 Cr. (Mar 2025) to 55.00 Cr., marking a decrease of 4.00 Cr..
- For OPM %, as of Jun 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 9.00% (Mar 2025) to 8.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
- For Interest, as of Jun 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 5.00 Cr. (Mar 2025) to 3.00 Cr., marking a decrease of 2.00 Cr..
- For Depreciation, as of Jun 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 53.00 Cr.. The value appears to be declining and may need further review. It has decreased from 55.00 Cr. (Mar 2025) to 53.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Jun 2025, the value is 19.00%. The value appears to be improving (decreasing) as expected. It has decreased from 20.00% (Mar 2025) to 19.00%, marking a decrease of 1.00%.
- For Net Profit, as of Jun 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Mar 2025) to 43.00 Cr., marking a decrease of 1.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 7.05. The value appears to be declining and may need further review. It has decreased from 7.32 (Mar 2025) to 7.05, marking a decrease of 0.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:51 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 635 | 805 | 752 | 834 | 1,326 | 1,269 | 1,003 | 1,447 | 2,132 | 2,249 | 2,357 | 2,793 | 2,890 |
| Expenses | 604 | 773 | 704 | 759 | 1,219 | 1,169 | 950 | 1,257 | 1,836 | 1,940 | 2,103 | 2,546 | 2,644 |
| Operating Profit | 31 | 32 | 48 | 75 | 108 | 100 | 53 | 190 | 296 | 309 | 254 | 247 | 246 |
| OPM % | 5% | 4% | 6% | 9% | 8% | 8% | 5% | 13% | 14% | 14% | 11% | 9% | 9% |
| Other Income | 1 | 1 | 2 | 4 | 2 | 3 | 4 | 6 | 6 | 7 | 14 | 12 | 15 |
| Interest | 6 | 8 | 8 | 9 | 14 | 25 | 17 | 9 | 7 | 12 | 18 | 18 | 15 |
| Depreciation | 2 | 3 | 5 | 5 | 5 | 6 | 7 | 8 | 8 | 9 | 10 | 12 | 14 |
| Profit before tax | 23 | 22 | 37 | 66 | 90 | 72 | 32 | 180 | 286 | 295 | 241 | 228 | 232 |
| Tax % | 22% | 18% | 31% | 33% | 32% | 27% | 10% | 25% | 20% | 21% | 19% | 18% | |
| Net Profit | 18 | 18 | 25 | 44 | 61 | 52 | 29 | 135 | 230 | 233 | 195 | 187 | 188 |
| EPS in Rs | 2.92 | 2.93 | 4.16 | 7.24 | 10.08 | 8.58 | 4.76 | 22.37 | 38.08 | 38.51 | 32.26 | 30.92 | 31.15 |
| Dividend Payout % | 26% | 46% | 8% | 9% | 12% | 14% | 25% | 9% | 21% | 21% | 22% | 10% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 38.89% | 76.00% | 38.64% | -14.75% | -44.23% | 365.52% | 70.37% | 1.30% | -16.31% | -4.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | 38.89% | 37.11% | -37.36% | -53.39% | -29.48% | 409.75% | -295.15% | -69.07% | -17.61% | 12.21% |
Panama Petrochem Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 23% |
| 3 Years: | 9% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 45% |
| 3 Years: | -7% |
| TTM: | -10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 41% |
| 3 Years: | -2% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 23% |
| 3 Years: | 20% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 12:05 pm
Balance Sheet
Last Updated: December 4, 2025, 1:46 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| Reserves | 231 | 241 | 264 | 305 | 359 | 402 | 421 | 549 | 756 | 940 | 1,091 | 1,243 | 1,328 |
| Borrowings | 17 | 42 | 57 | 33 | 45 | 160 | 51 | 66 | 30 | 0 | 26 | 33 | 31 |
| Other Liabilities | 205 | 207 | 162 | 323 | 559 | 346 | 273 | 366 | 455 | 282 | 281 | 236 | 262 |
| Total Liabilities | 461 | 498 | 492 | 669 | 976 | 919 | 757 | 993 | 1,253 | 1,235 | 1,409 | 1,524 | 1,633 |
| Fixed Assets | 77 | 119 | 123 | 125 | 134 | 156 | 173 | 185 | 230 | 248 | 287 | 312 | 310 |
| CWIP | 40 | 0 | 0 | 4 | 14 | 11 | 17 | 22 | 5 | 13 | 1 | 19 | 44 |
| Investments | 0 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 5 | 4 | 2 | 19 | 42 |
| Other Assets | 345 | 379 | 366 | 538 | 828 | 752 | 567 | 785 | 1,013 | 970 | 1,120 | 1,174 | 1,237 |
| Total Assets | 461 | 498 | 492 | 669 | 976 | 919 | 757 | 993 | 1,253 | 1,235 | 1,409 | 1,524 | 1,633 |
Below is a detailed analysis of the balance sheet data for Panama Petrochem Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,328.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,243.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 85.00 Cr..
- For Borrowings, as of Sep 2025, the value is 31.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 33.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 262.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 236.00 Cr. (Mar 2025) to 262.00 Cr., marking an increase of 26.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,633.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,524.00 Cr. (Mar 2025) to 1,633.00 Cr., marking an increase of 109.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 310.00 Cr.. The value appears to be declining and may need further review. It has decreased from 312.00 Cr. (Mar 2025) to 310.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 44.00 Cr., marking an increase of 25.00 Cr..
- For Investments, as of Sep 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2025) to 42.00 Cr., marking an increase of 23.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,237.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,174.00 Cr. (Mar 2025) to 1,237.00 Cr., marking an increase of 63.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,633.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,524.00 Cr. (Mar 2025) to 1,633.00 Cr., marking an increase of 109.00 Cr..
Notably, the Reserves (1,328.00 Cr.) exceed the Borrowings (31.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 14.00 | -10.00 | -9.00 | 42.00 | 63.00 | -60.00 | 2.00 | 124.00 | 266.00 | 309.00 | 228.00 | 214.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 96 | 79 | 75 | 80 | 77 | 90 | 91 | 82 | 54 | 57 | 63 | 66 |
| Inventory Days | 84 | 86 | 93 | 161 | 145 | 134 | 111 | 122 | 108 | 68 | 93 | 65 |
| Days Payable | 123 | 97 | 85 | 164 | 173 | 110 | 112 | 110 | 94 | 55 | 46 | 33 |
| Cash Conversion Cycle | 58 | 68 | 82 | 77 | 49 | 114 | 90 | 94 | 68 | 70 | 109 | 97 |
| Working Capital Days | 58 | 52 | 61 | 66 | 51 | 66 | 76 | 73 | 68 | 77 | 107 | 100 |
| ROCE % | 12% | 11% | 15% | 22% | 27% | 20% | 9% | 34% | 41% | 35% | 24% | 20% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Basic EPS (Rs.) | 30.92 | 32.26 | 38.51 | 38.08 | 22.37 |
| Diluted EPS (Rs.) | 30.92 | 32.26 | 38.51 | 38.08 | 22.37 |
| Cash EPS (Rs.) | 32.96 | 33.88 | 40.07 | 39.47 | 23.63 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 207.44 | 182.27 | 157.37 | 126.99 | 92.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 207.44 | 182.27 | 157.37 | 126.99 | 92.73 |
| Revenue From Operations / Share (Rs.) | 461.63 | 389.54 | 371.69 | 352.49 | 239.19 |
| PBDIT / Share (Rs.) | 42.80 | 44.39 | 52.16 | 49.88 | 32.41 |
| PBIT / Share (Rs.) | 40.75 | 42.77 | 50.60 | 48.49 | 31.15 |
| PBT / Share (Rs.) | 37.75 | 39.80 | 48.69 | 47.32 | 29.67 |
| Net Profit / Share (Rs.) | 30.91 | 32.26 | 38.51 | 38.08 | 22.37 |
| NP After MI And SOA / Share (Rs.) | 30.91 | 32.26 | 38.51 | 38.08 | 22.37 |
| PBDIT Margin (%) | 9.27 | 11.39 | 14.03 | 14.14 | 13.55 |
| PBIT Margin (%) | 8.82 | 10.97 | 13.61 | 13.75 | 13.02 |
| PBT Margin (%) | 8.17 | 10.21 | 13.09 | 13.42 | 12.40 |
| Net Profit Margin (%) | 6.69 | 8.28 | 10.36 | 10.80 | 9.35 |
| NP After MI And SOA Margin (%) | 6.69 | 8.28 | 10.36 | 10.80 | 9.35 |
| Return on Networth / Equity (%) | 14.90 | 17.69 | 24.46 | 29.98 | 24.12 |
| Return on Capital Employeed (%) | 18.99 | 23.17 | 31.78 | 37.73 | 32.98 |
| Return On Assets (%) | 12.27 | 13.84 | 18.86 | 18.38 | 13.63 |
| Total Debt / Equity (X) | 0.00 | 0.02 | 0.00 | 0.03 | 0.11 |
| Asset Turnover Ratio (%) | 1.90 | 1.78 | 1.49 | 1.48 | 1.53 |
| Current Ratio (X) | 5.18 | 3.81 | 3.56 | 2.13 | 1.86 |
| Quick Ratio (X) | 3.37 | 2.13 | 2.37 | 1.10 | 0.99 |
| Inventory Turnover Ratio (X) | 6.20 | 5.78 | 3.40 | 2.83 | 3.49 |
| Dividend Payout Ratio (NP) (%) | 19.40 | 24.79 | 23.36 | 10.50 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 18.20 | 23.60 | 22.45 | 10.13 | 0.00 |
| Earning Retention Ratio (%) | 80.60 | 75.21 | 76.64 | 89.50 | 0.00 |
| Cash Earning Retention Ratio (%) | 81.80 | 76.40 | 77.55 | 89.87 | 0.00 |
| Interest Coverage Ratio (X) | 14.26 | 14.95 | 27.27 | 42.75 | 21.92 |
| Interest Coverage Ratio (Post Tax) (X) | 11.30 | 11.87 | 21.14 | 33.64 | 16.13 |
| Enterprise Value (Cr.) | 2124.06 | 1894.57 | 1541.82 | 1494.48 | 870.27 |
| EV / Net Operating Revenue (X) | 0.76 | 0.80 | 0.68 | 0.70 | 0.60 |
| EV / EBITDA (X) | 8.20 | 7.05 | 4.89 | 4.95 | 4.44 |
| MarketCap / Net Operating Revenue (X) | 0.82 | 0.84 | 0.78 | 0.75 | 0.60 |
| Retention Ratios (%) | 80.59 | 75.20 | 76.63 | 89.49 | 0.00 |
| Price / BV (X) | 1.84 | 1.82 | 1.85 | 2.09 | 1.57 |
| Price / Net Operating Revenue (X) | 0.82 | 0.84 | 0.78 | 0.75 | 0.60 |
| EarningsYield | 0.08 | 0.09 | 0.13 | 0.14 | 0.15 |
After reviewing the key financial ratios for Panama Petrochem Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 30.92. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.92, marking a decrease of 1.34.
- For Diluted EPS (Rs.), as of Mar 25, the value is 30.92. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.92, marking a decrease of 1.34.
- For Cash EPS (Rs.), as of Mar 25, the value is 32.96. This value is within the healthy range. It has decreased from 33.88 (Mar 24) to 32.96, marking a decrease of 0.92.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 207.44. It has increased from 182.27 (Mar 24) to 207.44, marking an increase of 25.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 207.44. It has increased from 182.27 (Mar 24) to 207.44, marking an increase of 25.17.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 461.63. It has increased from 389.54 (Mar 24) to 461.63, marking an increase of 72.09.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 42.80. This value is within the healthy range. It has decreased from 44.39 (Mar 24) to 42.80, marking a decrease of 1.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 40.75. This value is within the healthy range. It has decreased from 42.77 (Mar 24) to 40.75, marking a decrease of 2.02.
- For PBT / Share (Rs.), as of Mar 25, the value is 37.75. This value is within the healthy range. It has decreased from 39.80 (Mar 24) to 37.75, marking a decrease of 2.05.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 30.91. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.91, marking a decrease of 1.35.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 30.91. This value is within the healthy range. It has decreased from 32.26 (Mar 24) to 30.91, marking a decrease of 1.35.
- For PBDIT Margin (%), as of Mar 25, the value is 9.27. This value is below the healthy minimum of 10. It has decreased from 11.39 (Mar 24) to 9.27, marking a decrease of 2.12.
- For PBIT Margin (%), as of Mar 25, the value is 8.82. This value is below the healthy minimum of 10. It has decreased from 10.97 (Mar 24) to 8.82, marking a decrease of 2.15.
- For PBT Margin (%), as of Mar 25, the value is 8.17. This value is below the healthy minimum of 10. It has decreased from 10.21 (Mar 24) to 8.17, marking a decrease of 2.04.
- For Net Profit Margin (%), as of Mar 25, the value is 6.69. This value is within the healthy range. It has decreased from 8.28 (Mar 24) to 6.69, marking a decrease of 1.59.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.69. This value is below the healthy minimum of 8. It has decreased from 8.28 (Mar 24) to 6.69, marking a decrease of 1.59.
- For Return on Networth / Equity (%), as of Mar 25, the value is 14.90. This value is below the healthy minimum of 15. It has decreased from 17.69 (Mar 24) to 14.90, marking a decrease of 2.79.
- For Return on Capital Employeed (%), as of Mar 25, the value is 18.99. This value is within the healthy range. It has decreased from 23.17 (Mar 24) to 18.99, marking a decrease of 4.18.
- For Return On Assets (%), as of Mar 25, the value is 12.27. This value is within the healthy range. It has decreased from 13.84 (Mar 24) to 12.27, marking a decrease of 1.57.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.90. It has increased from 1.78 (Mar 24) to 1.90, marking an increase of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 5.18. This value exceeds the healthy maximum of 3. It has increased from 3.81 (Mar 24) to 5.18, marking an increase of 1.37.
- For Quick Ratio (X), as of Mar 25, the value is 3.37. This value exceeds the healthy maximum of 2. It has increased from 2.13 (Mar 24) to 3.37, marking an increase of 1.24.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.20. This value is within the healthy range. It has increased from 5.78 (Mar 24) to 6.20, marking an increase of 0.42.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.40. This value is below the healthy minimum of 20. It has decreased from 24.79 (Mar 24) to 19.40, marking a decrease of 5.39.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 18.20. This value is below the healthy minimum of 20. It has decreased from 23.60 (Mar 24) to 18.20, marking a decrease of 5.40.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.60. This value exceeds the healthy maximum of 70. It has increased from 75.21 (Mar 24) to 80.60, marking an increase of 5.39.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 81.80. This value exceeds the healthy maximum of 70. It has increased from 76.40 (Mar 24) to 81.80, marking an increase of 5.40.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 14.26. This value is within the healthy range. It has decreased from 14.95 (Mar 24) to 14.26, marking a decrease of 0.69.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.30. This value is within the healthy range. It has decreased from 11.87 (Mar 24) to 11.30, marking a decrease of 0.57.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,124.06. It has increased from 1,894.57 (Mar 24) to 2,124.06, marking an increase of 229.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has decreased from 0.80 (Mar 24) to 0.76, marking a decrease of 0.04.
- For EV / EBITDA (X), as of Mar 25, the value is 8.20. This value is within the healthy range. It has increased from 7.05 (Mar 24) to 8.20, marking an increase of 1.15.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.82, marking a decrease of 0.02.
- For Retention Ratios (%), as of Mar 25, the value is 80.59. This value exceeds the healthy maximum of 70. It has increased from 75.20 (Mar 24) to 80.59, marking an increase of 5.39.
- For Price / BV (X), as of Mar 25, the value is 1.84. This value is within the healthy range. It has increased from 1.82 (Mar 24) to 1.84, marking an increase of 0.02.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.84 (Mar 24) to 0.82, marking a decrease of 0.02.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.08, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Panama Petrochem Ltd:
- Net Profit Margin: 6.69%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 18.99% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 14.9% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.3
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.37
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.9 (Industry average Stock P/E: 74.84)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.69%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Lubricants | Plot No. 3303, Ankleshwar Gujarat 393002 | ankl@panamapetro.com http://www.panamapetro.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Amirali E Rayani | Executive Chairman |
| Mr. Samir A Rayani | Managing Director & CEO |
| Mr. Hussein V Rayani | Joint Managing Director |
| Mr. Arif A Rayani | Executive Director |
| Mr. Kumar Raju Nandimandalam | Ind. Non-Executive Director |
| Mr. Ashok Mukhi | Ind. Non-Executive Director |
| Mr. Arvind Shah | Ind. Non-Executive Director |
| Ms. Almas Nanda | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Panama Petrochem Ltd?
Panama Petrochem Ltd's intrinsic value (as of 20 December 2025) is 255.85 which is 7.64% lower the current market price of 277.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,677 Cr. market cap, FY2025-2026 high/low of 411/264, reserves of ₹1,328 Cr, and liabilities of 1,633 Cr.
What is the Market Cap of Panama Petrochem Ltd?
The Market Cap of Panama Petrochem Ltd is 1,677 Cr..
What is the current Stock Price of Panama Petrochem Ltd as on 20 December 2025?
The current stock price of Panama Petrochem Ltd as on 20 December 2025 is 277.
What is the High / Low of Panama Petrochem Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Panama Petrochem Ltd stocks is 411/264.
What is the Stock P/E of Panama Petrochem Ltd?
The Stock P/E of Panama Petrochem Ltd is 8.90.
What is the Book Value of Panama Petrochem Ltd?
The Book Value of Panama Petrochem Ltd is 222.
What is the Dividend Yield of Panama Petrochem Ltd?
The Dividend Yield of Panama Petrochem Ltd is 1.80 %.
What is the ROCE of Panama Petrochem Ltd?
The ROCE of Panama Petrochem Ltd is 20.4 %.
What is the ROE of Panama Petrochem Ltd?
The ROE of Panama Petrochem Ltd is 15.9 %.
What is the Face Value of Panama Petrochem Ltd?
The Face Value of Panama Petrochem Ltd is 2.00.